产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | RBE (人肝胆管癌细胞) (STR鉴定正确) |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:2-1:3 |
推荐换液频率 | 2-3次/周 |
背景描述 | RBE细胞是一株人肝胆管癌细胞;据说,RBE细胞可产CEA和CA19-9。 |
年龄(性别) | 女性 |
组织来源 | 肝 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肝胆癌细胞 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 12 D2S1338 17,24 D3S1358 14,15 D5S818 11,12 D7S820 8,11 D8S1179 13,14 D13S317 9 D16S539 10,11 D18S51 13,15 D19S433 14,15.2 D21S11 29 FGA 19,24 PentaD 12 PentaE 18 TH01 6 TPOX 8 vWA 20 D6S1043 14 D12S391 18 D2S441 10,11 -
STR鉴定图
参考文献
-
METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10(2022/12/07)
作者:Jingli Cai, Zheng Cui, Jingyi Zhou
期刊:Cancer Cell International
DOI:10.1186/s12935-022-02809-2
影响因子 :5.800
-
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma(2020/11/10)
作者:Xiangyu Zhai, Wei Wang, Yunlong Ma
期刊:Aging-US
影响因子 :5.200
-
Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma(2023/06/05)
作者:Wei Zhao, Jing Zhao, Kun Li
期刊:LABORATORY INVESTIGATION
DOI:10.1016/j.labinv.2023.100193
影响因子 :5.000
-
SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis(2023/03/01)
作者:Fanghua Chen, Ling Aye, Lei Yu
期刊:CARCINOGENESIS
影响因子 :4.700
引用产品:CL-0191
-
Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis(2024/02/28)
作者:Chao Zhang, Chengkun Qin
期刊:Human Cell
DOI:10.1007/s13577-024-01032-7
影响因子 :4.300
引用产品:CL-0191
-
LncRNA-HANR exacerbates malignant behaviors of cholangiocarcinoma cells through activating Notch pathway(2023/11/11)
作者:Guoqing Zhou, Hongwei He, Xuan Wang
期刊:Heliyon
DOI:10.1016/j.heliyon.2023.e22087
影响因子 :4.000
引用产品:CL-0191
-
Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin(2018/05/25)
作者:Qixiang Ma, Yanyan Feng, Kaiwen Deng
期刊:Journal of Cancer
影响因子 :3.900
-
LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis(2021/2/8)
作者:Wei Zhao, Jing Zhao, Xiao Guo
期刊:Bmc Cancer
DOI:10.1186/s12885-021-07838-0
影响因子 :3.800
-
Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1(2024/04/04)
作者:Jiong Li, Xiangjun Ma, Faying Xu
期刊:PHARMACEUTICAL BIOLOGY
DOI:10.1080/13880209.2024.2331060
影响因子 :3.800
引用产品:CL-0191
-
Clonorchis sinensis legumain promotes migration and invasion of cholangiocarcinoma cells via regulating tumor-related molecules(2023/02/16)
作者:Yanfei Chu, Doufei Shi, Nan Wang
期刊:Parasites & Vectors
DOI:10.1186/s13071-023-05694-4
影响因子 :3.200
引用产品:CL-0191
-
Hsa_circ_0019054 up-regulates HIF1A through sequestering miR-340–5p to promote the tumorigenesis of intrahepatic cholangiocarcinoma(2022/12/06)
作者:Jintian Tang, Runjuan Tang, Peng Gu
期刊:HUMAN & EXPERIMENTAL TOXICOLOGY
影响因子 :2.800
-
Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression.(2022/11/04)
作者:Sun J, Feng M, Zou H, Mao Y, Yu W
期刊:HISTOLOGY AND HISTOPATHOLOGY
影响因子 :2.000
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图